ClinicalTrials.Veeva

Menu

Control of Colic in Infants by Dietary Supplementation With the Probiotic Lactobacillus Reuteri

C

Children's Investigational Research Program, LLC

Status and phase

Unknown
Phase 4

Conditions

Colic

Treatments

Dietary Supplement: Lactobacillus reuteri

Study type

Interventional

Funder types

Other

Identifiers

NCT01067027
Colic001

Details and patient eligibility

About

It is believed that probiotic Lactobacillus reuteri will improve the symptoms of breast-fed infants with colic.

Enrollment

50 estimated patients

Sex

All

Ages

14 to 60 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ifants aged between 14 and 60 days
  • Breast fed, exclusively during length of trial
  • Diagnosis of infantile colic according to Wessel's criteria i.e paroxysmal fussing in infancy for more than three hours per day, at least three days per week.
  • Debut of colic symptoms 6+/-1 days before randomization
  • Gestational age between 37 and 42 weeks
  • Apgar score higher than 7 at 5 minutes
  • Mothers willing to follow a cows mild-free diet (free from mild, yoghurt, cheese etc) during the study period
  • Written informed consent from one or both parents
  • Stated availability throughout the study period

Exclusion criteria

  • Major chronic disease
  • Gastrointestinal disease but controlled GERD with or without medication is not an exclusion criteria
  • Administration of anitbiotics the week before randomization
  • Administration of probiotics the week before randomization
  • Participation in other clinical trials

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Quadruple Blind

Trial contacts and locations

1

Loading...

Central trial contact

Misty R Ross, MA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems